Treatment of refractory chronic lymphocytic leukemia may include the following:
- Repeat treatment with monoclonal antibody therapy and combination chemotherapy.
- A clinical trial of chemotherapy with stem cell transplant.
- A clinical trial of a new treatment.
Check the list of NCI-supported cancer clinical trials that are now accepting patients with refractory chronic lymphocytic leukemia. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.